Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $7.32 Million - $8.34 Million
-129,215 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $7.7 Million - $9.68 Million
123,970 Added 2363.58%
129,215 $8.17 Million
Q2 2020

Jul 31, 2020

SELL
$72.34 - $84.0 $609,464 - $707,700
-8,425 Reduced 61.63%
5,245 $404,000
Q1 2020

May 07, 2020

BUY
$62.63 - $80.22 $227,033 - $290,797
3,625 Added 36.09%
13,670 $1.02 Million
Q4 2019

Jan 23, 2020

SELL
$61.62 - $67.78 $647,626 - $712,367
-10,510 Reduced 51.13%
10,045 $653,000
Q3 2019

Nov 01, 2019

BUY
$62.51 - $69.0 $138,772 - $153,180
2,220 Added 12.11%
20,555 $1.3 Million
Q2 2019

Aug 07, 2019

SELL
$61.87 - $69.38 $15,467 - $17,345
-250 Reduced 1.35%
18,335 $1.24 Million
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $1.16 Million - $1.3 Million
18,585 New
18,585 $1.21 Million
Q4 2018

Feb 15, 2019

SELL
$60.54 - $79.0 $777,636 - $1.01 Million
-12,845 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $14,256 - $15,784
200 Added 1.58%
12,845 $992,000
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $366,247 - $427,213
5,645 Added 80.64%
12,645 $896,000
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $25,494 - $31,080
350 Added 5.26%
7,000 $528,000
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $64,035 - $75,168
-900 Reduced 11.92%
6,650 $476,000
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $544,430 - $645,298
7,550
7,550 $612,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.